Extended Interval Dosing of Ocrelizumab in Patients with Multiple Sclerosis Is Not Associated with Meaningful Differences in Disease Activity

被引：0
|
作者：
Rjeily, N. Bou [1 ]
Fitzgerald, K. C. [1 ]
Mowry, E. M. [1 ]
机构：
[1] Johns Hopkins Univ, Neurol, Baltimore, MD USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P164
引用
下载
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] HEALTHCARE RESOURCE UTILIZATION AND COSTS FOR EXTENDED INTERVAL DOSING OF NATALIZUMAB IN RELAPSING REMITTING MULTIPLE SCLEROSIS
    Moccia, M.
    Loperto, I
    Santoni, L.
    Masera, S.
    Carotenuto, A.
    Triassi, M.
    Morra, Brescia, V
    Palladino, R.
    VALUE IN HEALTH, 2020, 23 : S531 - S531
  • [42] Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
    Maria Cellerino
    Giacomo Boffa
    Caterina Lapucci
    Francesco Tazza
    Elvira Sbragia
    Elisabetta Mancuso
    Nicolò Bruschi
    Simona Minguzzi
    Federico Ivaldi
    Ilaria Poirè
    Alice Laroni
    Gianluigi Mancardi
    Elisabetta Capello
    Antonio Uccelli
    Giovanni Novi
    Matilde Inglese
    Neurotherapeutics, 2021, 18 : 2579 - 2588
  • [43] Effectiveness and safety of ocrelizumab in patients with multiple sclerosis
    Madrid-Paredes, A.
    Alvarez-Sanchez, R.
    Nieto-Gomez, P.
    Portillo-Haro, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 287 - 287
  • [44] Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
    Cellerino, Maria
    Boffa, Giacomo
    Lapucci, Caterina
    Tazza, Francesco
    Sbragia, Elvira
    Mancuso, Elisabetta
    Bruschi, Nicolo
    Minguzzi, Simona
    Ivaldi, Federico
    Poire, Ilaria
    Laroni, Alice
    Mancardi, Gianluigi
    Capello, Elisabetta
    Uccelli, Antonio
    Novi, Giovanni
    Inglese, Matilde
    NEUROTHERAPEUTICS, 2021, 18 (04) : 2579 - 2588
  • [45] Predictors of ocrelizumab effectiveness in patients with multiple sclerosis
    Cellerino, Maria
    Boffa, Giacomo
    Lapucci, Caterina
    Tazza, Francesco
    Sbragia, Elvira
    Mancuso, Elisabetta
    Bruschi, Nicolo
    Minguzzi, Simona
    Ivaldi, Federico
    Poire, Ilaria
    Laroni, Alice
    Mancardi, Gian Luigi
    Capello, Elisabetta
    Uccelli, Antonio
    Novi, Giovanni
    Inglese, Matilde
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [46] Neutropenia associated with Ocrelizumab in a multiple sclerosis progresive patient
    Meca-Lallana, V.
    Aguirre, C.
    Sanchez, P.
    del Rio, B.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 879 - 879
  • [47] Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue
    Viti, Vittorio
    Zanetta, Chiara
    Capra, Ruggero
    Municchi, Andrea
    Rocca, Maria A.
    Filippi, Massimo
    JOURNAL OF NEUROLOGY, 2024, 271 (09) : 6368 - 6376
  • [48] Evaluation of anti-JC virus index values in multiple sclerosis patients on Natalizumab extended interval dosing and standard interval dosing: an analysis of the TOUCH® prescribing program database
    Foley, J.
    Ryerson, L. Zhovtis
    Chang, I.
    Kister, I.
    Cutter, G.
    Metzger, R.
    Riddle, E.
    Ren, Z.
    Hotermans, C.
    Mason, L.
    Ho, P. -R.
    Campbell, N.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 329 - 330
  • [49] Ocrelizumab extended interval dosing compared to standard dosing - a safe alternative with significantly decreased immunoglobulin M deficiency rates
    Rempe, T.
    Elfasi, A.
    Rodriguez, E.
    Vasquez, M.
    Graves, J.
    Kinkel, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 958 - 959
  • [50] A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis
    Iaffaldano, Pietro
    Lucisano, Giuseppe
    Guerra, Tommaso
    Paolicelli, Damiano
    Portaccio, Emilio
    Inglese, Matilde
    Foschi, Matteo
    Patti, Francesco
    Granella, Franco
    Romano, Silvia
    Cavalla, Paola
    De Luca, Giovanna
    Gallo, Paolo
    Bellantonio, Paolo
    Gallo, Antonio
    Montepietra, Sara
    Di Sapio, Alessia
    Vianello, Marika
    Quatrale, Rocco
    Spitaleri, Daniele
    Clerici, Raffaella
    Clerici, Valentina Torri
    Cocco, Eleonora
    Morra, Vincenzo Brescia
    Marfia, Girolama Alessandra
    Boccia, Vincenzo Daniele
    Filippi, Massimo
    Amato, Maria Pia
    Trojano, Maria
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (08): : 2008 - 2015
12345